Etobicoke, Canada Clinical Trials

A listing of Etobicoke, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 62 clinical trials
ZYNRELEF® for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy (HeronBariatric) PUBLISHED

Approximately 120 subjects will be randomized into 1 of the following 2 treatment groups in a 1:1 ratio:Group 1: ZYNRELEF® up to 200 mg/ 6mg ( 7ml vial) via instillation at all incision sites in addition to 30 ml of 0.5% Ropivacaine + 10mg dexamethasone. Postoperatively, intermittent IV acetaminophen will …

New Site for Canada
 (1.4 away) Contact site
  • 0 views
  • 09 Jul, 2026
  • +3 other locations
None

Sunnybrook Health Sciences Centre
 (9.7 away) Contact site
  • 0 views
  • 19 May, 2025
  • +19 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

body mass index
tirzepatide
dulaglutide
cardiovascular disease
Diabetes Heart Research Center
 (5.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +650 other locations
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

cancer therapy
endometrial cancer
maintenance therapy
durvalumab
measurable disease
Research Site
 (6.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +94 other locations
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients

Anesthesia is a drug induced, reversible, comatose state that facilitates surgery and it is widely assumed that cognition returns to baseline after anesthetics have been eliminated. However, many patients have persistent memory impairment for weeks to months after surgery. Cardiac surgery appears to carry the highest risk of postoperative cognitive …

coma
anesthetics
thoracotomy
cognitive deficits
cognitive disorder
Sunnybrook Health Sciences Centre
 (9.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Prone Positioning for Patients on General Medical Wards With COVID19

COVID-PRONE is a multicenter, pragmatic, single-blind, 2-arm, parallel, randomized controlled trial seeking to compare the pre-emptive prone positioning (i.e. encouraging patients to adopt a prone position before they require mechanical ventilation) to the control arm of standard care alone. Randomization will be stratified by site.

FIO2
mechanical ventilation
covid-19
nosocomial infection
fraction of inspired oxygen (fio2)
Toronto Western Hospital
 (5.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19

This is a 14-day long prospective, multi-site, two-armed, randomized, open-label study that will enroll approximately 100 adult outpatients in Canada who have received a positive SARS-CoV-2 test result within the preceding 72 hours. Participants will be randomized (1:1) to receive either icosapent ethyl (4 g BID for 3 days, then …

pharyngitis
icosapent ethyl
sore throat
covid-19
throat
North York Diagnostic and Cardiology Clinic
 (6.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:

Stereotactic Ablative Body Radiotherapy (SABR) given in 5 weekly fractions. Simultaneously treating the pelvic lymph nodes, prostate and MRI-nodule to a total dose of 25 Gy, 35 Gy and up to 50 Gy, respectively. The radiation will be given with 6-18 months of ADT. 5-fraction SABR is a feasible, well-tolerated, …

stereotactic body radiation therapy
adenocarcinoma of prostate
adenocarcinoma
Sunnybrook Health Sciences Center
 (9.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Hyperpolarized Imaging for New Treatments

The introduction of triple combination CFTR modulator therapy for patients with Cystic Fibrosis (CF) with at least one copy of the deltaF508 mutation is expected to provide major health benefits, but will also require novel outcome measures that can detect CF lung disease at an early stage, capture the efficacy …

multiple breath washout
cystic fibrosis
pilocarpine
pulmonary function test
antibiotics
The Hospital for Sick Kids
 (6.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
A Study to Evaluate the Safety Pharmacokinetics and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

solid tumor
kras g12c mutation
kras
metastatic malignant solid tumor
solid tumour
Princess Margaret Cancer Centre
 (6.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +7 other locations